News

Hollings researchers uncovered data showing that women who survive cervical cancer are at greater risk of anal cancer years down the road.

A clinical trial at Hollings is looking for answers to a problem that Dr. Avi Siva saw was affecting her triple negative breast cancer patients.

MUSC study finds a link between inflammation and poor neonatal and pregnancy outcomes.

New trial to test whether quit-smoking medication works to help people to quit vaping.

MUSC researchers have engineered a new type of genetically modified immune cell that could help organ transplant patients who are prone to rejection.

Many people remain unaware that HPV can cause six types of cancer – and that can affect whether people choose to vaccinate.

Counties with historically lower rates of screening for cervical cancer have higher rates of late-stage diagnosis and death.

An MUSC study lays the scientific groundwork for a new approach to preventing compromised kidney function and kidney failure in patients with lupus.

A new modeling study provides insight for guideline-writing bodies on who should be screened for anal cancer, how often and with which method.

With $26.5 million in new funding, SCTR will clear the way for the translation of research breakthroughs into clinics and communities.